193 related articles for article (PubMed ID: 34627174)
1. Differences in peripheral neuropathy in xeroderma pigmentosum complementation groups A and D as evaluated by nerve conduction studies.
Lehky TJ; Sackstein P; Tamura D; Quezado M; Wu T; Khan SG; Patronas NJ; Wiggs E; Brewer CC; DiGiovanna JJ; Kraemer KH
BMC Neurol; 2021 Oct; 21(1):393. PubMed ID: 34627174
[TBL] [Abstract][Full Text] [Related]
2. The influence of DNA repair on neurological degeneration, cachexia, skin cancer and internal neoplasms: autopsy report of four xeroderma pigmentosum patients (XP-A, XP-C and XP-D).
Lai JP; Liu YC; Alimchandani M; Liu Q; Aung PP; Matsuda K; Lee CC; Tsokos M; Hewitt S; Rushing EJ; Tamura D; Levens DL; Digiovanna JJ; Fine HA; Patronas N; Khan SG; Kleiner DE; Oberholtzer JC; Quezado MM; Kraemer KH
Acta Neuropathol Commun; 2013 May; 1():4. PubMed ID: 24252196
[TBL] [Abstract][Full Text] [Related]
3. Neurological symptoms and natural course of xeroderma pigmentosum.
Anttinen A; Koulu L; Nikoskelainen E; Portin R; Kurki T; Erkinjuntti M; Jaspers NG; Raams A; Green MH; Lehmann AR; Wing JF; Arlett CF; Marttila RJ
Brain; 2008 Aug; 131(Pt 8):1979-89. PubMed ID: 18567921
[TBL] [Abstract][Full Text] [Related]
4. Auditory analysis of xeroderma pigmentosum 1971-2012: hearing function, sun sensitivity and DNA repair predict neurological degeneration.
Totonchy MB; Tamura D; Pantell MS; Zalewski C; Bradford PT; Merchant SN; Nadol J; Khan SG; Schiffmann R; Pierson TM; Wiggs E; Griffith AJ; DiGiovanna JJ; Kraemer KH; Brewer CC
Brain; 2013 Jan; 136(Pt 1):194-208. PubMed ID: 23365097
[TBL] [Abstract][Full Text] [Related]
5. Cockayne syndrome and xeroderma pigmentosum.
Rapin I; Lindenbaum Y; Dickson DW; Kraemer KH; Robbins JH
Neurology; 2000 Nov; 55(10):1442-9. PubMed ID: 11185579
[TBL] [Abstract][Full Text] [Related]
6. Adult-onset xeroderma pigmentosum neurological disease--observations in an autopsy case.
Robbins JH; Kraemer KH; Merchant SN; Brumback RA
Clin Neuropathol; 2002; 21(1):18-23. PubMed ID: 11846040
[TBL] [Abstract][Full Text] [Related]
7. Detailed Audiological Evaluation of a Patient with Xeroderma Pigmentosum with Neural Degeneration.
Mercer D; Hurley A; Tsien F
J Am Acad Audiol; 2017 Jan; 28(1):80-90. PubMed ID: 28054914
[TBL] [Abstract][Full Text] [Related]
8. Neurological disease in xeroderma pigmentosum: prospective cohort study of its features and progression.
Garcia-Moreno H; Langbehn DR; Abiona A; Garrood I; Fleszar Z; Manes MA; Morley AMS; Craythorne E; Mohammed S; Henshaw T; Turner S; Naik H; Bodi I; Sarkany RPE; Fassihi H; Lehmann AR; Giunti P
Brain; 2023 Dec; 146(12):5044-5059. PubMed ID: 38040034
[TBL] [Abstract][Full Text] [Related]
9. Clinical symptoms and DNA repair characteristics of xeroderma pigmentosum patients from Germany.
Thielmann HW; Popanda O; Edler L; Jung EG
Cancer Res; 1991 Jul; 51(13):3456-70. PubMed ID: 2054785
[TBL] [Abstract][Full Text] [Related]
10. Clinical, genetic and DNA repair studies on a consecutive series of patients with xeroderma pigmentosum.
Pawsey SA; Magnus IA; Ramsay CA; Benson PF; Giannelli F
Q J Med; 1979 Apr; 48(190):179-210. PubMed ID: 504548
[TBL] [Abstract][Full Text] [Related]
11. Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair.
Bradford PT; Goldstein AM; Tamura D; Khan SG; Ueda T; Boyle J; Oh KS; Imoto K; Inui H; Moriwaki S; Emmert S; Pike KM; Raziuddin A; Plona TM; DiGiovanna JJ; Tucker MA; Kraemer KH
J Med Genet; 2011 Mar; 48(3):168-76. PubMed ID: 21097776
[TBL] [Abstract][Full Text] [Related]
12. Spotlight on 'xeroderma pigmentosum'.
Fassihi H
Photochem Photobiol Sci; 2013 Jan; 12(1):78-84. PubMed ID: 23132518
[TBL] [Abstract][Full Text] [Related]
13. Analysis of point mutations in an ultraviolet-irradiated shuttle vector plasmid propagated in cells from Japanese xeroderma pigmentosum patients in complementation groups A and F.
Yagi T; Tatsumi-Miyajima J; Sato M; Kraemer KH; Takebe H
Cancer Res; 1991 Jun; 51(12):3177-82. PubMed ID: 2039995
[TBL] [Abstract][Full Text] [Related]
14. Peripheral neuropathy in four cases of group A xeroderma pigmentosum.
Tachi N; Sasaki K; Kusano T; Wakai S; Nagaoka M; Annaka S; Minami R; Imamura S
J Child Neurol; 1988 Apr; 3(2):114-9. PubMed ID: 2836498
[TBL] [Abstract][Full Text] [Related]
15. Patients with xeroderma pigmentosum complementation groups C, E and V do not have abnormal sunburn reactions.
Sethi M; Lehmann AR; Fawcett H; Stefanini M; Jaspers N; Mullard K; Turner S; Robson A; McGibbon D; Sarkany R; Fassihi H
Br J Dermatol; 2013 Dec; 169(6):1279-87. PubMed ID: 23889214
[TBL] [Abstract][Full Text] [Related]
16. [Xeroderma pigmentosum].
Takeuchi S
Nihon Rinsho; 2000 Jul; 58(7):1496-500. PubMed ID: 10921330
[TBL] [Abstract][Full Text] [Related]
17. Xeroderma pigmentosum complementation group G associated with Cockayne syndrome.
Vermeulen W; Jaeken J; Jaspers NG; Bootsma D; Hoeijmakers JH
Am J Hum Genet; 1993 Jul; 53(1):185-92. PubMed ID: 8317483
[TBL] [Abstract][Full Text] [Related]
18. Xeroderma pigmentosum: neurological, neurophysiological and morphological studies.
Hakamada S; Watanabe K; Sobue G; Hara K; Miyazaki S
Eur Neurol; 1982; 21(2):69-76. PubMed ID: 6284512
[TBL] [Abstract][Full Text] [Related]
19. Histopathology of the inner ear in patients with xeroderma pigmentosum and neurologic degeneration.
Viana LM; Seyyedi M; Brewer CC; Zalewski C; DiGiovanna JJ; Tamura D; Totonchy M; Kraemer KH; Nadol JB
Otol Neurotol; 2013 Sep; 34(7):1230-6. PubMed ID: 23928520
[TBL] [Abstract][Full Text] [Related]
20. Xeroderma pigmentosum--bridging a gap between clinic and laboratory.
Moriwaki S; Kraemer KH
Photodermatol Photoimmunol Photomed; 2001 Apr; 17(2):47-54. PubMed ID: 11338401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
